Search results for: “pharmaceutical companies”
-
Tryp Therapeutics appoints Greg McKee as Chief Executive Officer
•
SAN DIEGO: Tryp Therapeutics Inc. has appointed Greg McKee as its Chief Executive Officer, a news release said.…
-
Instem plc acquires The Edge Software Consultancy for £8.5 million
•
LONDON: Instem plc, a leading provider of IT solutions, has acquired the entire issued share capital of The…
-
Starpharma Holdings Limited (ASX:SPL)
•
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company…
-
An van Es Johansson resigns as board director in BioInvent International
•
LUND, SWEDEN: BioInvent International AB announced that An van Es Johansson will resign as a director of the…
-
Probiotec Limited completes acquisition of Multipack-LJM
•
SYDNEY: Probiotec Limited has today completed the acquisition of the Multipack LJM business as first announced on 10…
-
Michael Bell appointed new Chief Financial Officer of Guardant Health
•
REDWOOD CITY: Guardant Health Inc. has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective…
-
Trinity Life Sciences acquires BluePrint Research Group
•
WALTHAM: Trinity Life Sciences announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity as…
-
Takashi Nagao appointed President and CEO of Medicago
•
QUEBEC CITY: Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced Takashi Nagao as the company’s new…
-
Uniphar plc announces acquisition of RRD International
•
DUBLIN: Uniphar plc has announced the acquisition of US-based, RRD International. RRD is a US based pharmaceutical advisory…
-
AbCellera Biologics acquires Trianni Inc. for $90 million
•
VANCOUVER: AbCellera Biologics has acquired Trianni Inc. in an all-cash transaction valued at US$90 million, a news release…
-
Sumitovant Biopharma will acquire Urovant Sciences for $584 million
•
IRVINE: Urovant Sciences has entered into a definitive agreement in which Sumitovant Biopharma will acquire Urovant Sciences for…
-
Oncimmune signs agreement with Augmenta Bioworks to discover therapeutic antibodies
•
LONDON: Oncimmune Holdings plc has signed a new master service agreement with Augmenta Bioworks Inc. to profile patient…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.